S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Novavax Announces Ebola Vaccine Development Program at the 8th Vaccine and ISV Conference in Philadelphia|
|U.S. FDA Grants Fast Track Designation to Novavax' H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M(TM)|
|Novavax Reports Third Quarter 2014 Financial Results|
|Novavax Initiates Phase 2 Clinical Trial of Quadrivalent Seasonal Influenza VLP|
|U.S. FDA Grants Fast Track Designation to Novavax' RSV F-Protein Nanoparticle Vaccine for Protection of Infants Via Maternal Immunization|
|Novavax Study Published in Vaccine: RSV F-Protein Nanoparticle Vaccine Induces Antigenic Site II Antibodies|
|Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine in Elderly Subjects|
|Novavax Presents RSV F Protein Nanoparticle Vaccine Clinical Data at the 8th Vaccine & ISV Congress in Philadelphia on Sunday, October 26|
|Novavax Initiates Phase 1 Clinical Trial of RSV F Vaccine in Pediatric Subjects|
|Novavax's stock surges after news of Ebola vaccine candidate trial|
Click above to view more mutual fund data and stats for nvax - Novavax Inc.